XERS — Xeris Biopharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for Xeris Biopharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	102	122	72.5	71.6	111
Net Total Accounts Receivable
Net Total Receivables	17.5	30.8	39.2	40.4	51
Total Inventory
Prepaid Expenses
Total Current Assets	143	187	156	168	240
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.63	9.51	29.2	28.2	27.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	304	345	323	323	384
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	79	73.6	95.2	100	110
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	209	299	329	353	370
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	95.2	45.2	-6.78	-29.6	13.7
Total Liabilities & Shareholders' Equity	304	345	323	323	384
Total Common Shares Outstanding